Related Experiment Video

Updated: May 9, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Genetic mutations governing ferroptosis sensitivity and resistance: a precision approach to cancer therapy

Peyman Tabnak1, Mohammad Ebrahimnezhad2,3, Zanyar HajiEsmailPoor4

  • 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. drtabnak@gmail.com.

Cell Death & Disease
|May 7, 2026
PubMed

Insights

Ferroptosis, an iron-dependent cell death pathway, offers new cancer treatment strategies. Understanding how genetic mutations affect ferroptosis is key to overcoming treatment resistance and advancing precision oncology.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Ferroptosis is an iron-dependent programmed cell death pathway crucial in cancer therapy.
  • Lipid peroxidation drives ferroptosis, presenting unique vulnerabilities in cancer cells.
  • Understanding ferroptosis mechanisms is vital for developing novel anti-cancer strategies.

Purpose of the Study:

  • To review the molecular mechanisms of ferroptosis.
  • To explore how genetic mutations in various cancers modulate ferroptosis.
  • To highlight the potential of ferroptosis-targeted therapies in precision oncology.

Main Methods:

  • Comprehensive literature review of ferroptosis mechanisms and genetic mutations.
  • Analysis of ferroptosis regulators (GPX4, system Xc⁻, iron metabolism proteins).
  • Examination of oncogenic mutations (EGFR, KRAS, TP53, KEAP1, IDH1) and their impact on ferroptosis.

Main Results:

  • Ferroptosis regulators maintain the balance between oxidative damage and antioxidant defense.
  • Specific oncogenic mutations alter ferroptosis susceptibility by affecting metabolism and redox homeostasis.
  • Mutation-specific sensitivities to ferroptosis are identified across multiple cancer types.

Conclusions:

  • Ferroptosis-targeted strategies can overcome therapeutic resistance in diverse cancers.
  • Synergistic effects observed between ferroptosis induction and conventional treatments (chemotherapy, immunotherapy).
  • This research advances precision oncology by leveraging ferroptosis vulnerabilities for improved clinical outcomes.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.